DOWNERS GROVE, Ill., – Dover announced today that it has entered into a definitive agreement to acquire Em-tec GmbH (“Em-tec”), a designer and manufacturer of flow measurement devices that serve a wide array of medical and biopharmaceutical applications. Following the close of the transaction, Em-tec will become part of the PSG business unit within Dover’s Pumps & Process Solutions segment.
Em-tec is headquartered in Finning, Germany, and has a 30-year history of producing innovative flow measurement equipment used in connection with cardiac, vascular and transplant surgery, dialysis and “life support” procedures, automated bioprocess monitoring, and laboratory and industrial processes where flexible tubing is used.
The addition of Em-tec further expands Dover’s reach into biopharma and other hygienic applications and adds to its portfolio of flow control technologies with flow rate sensors.
“We are excited to bring together Em-tec’s flow measurement devices and PSG’s Quattroflow pump technology to expand our offering to our customers in biopharma and medical applications,” said Richard J. Tobin, Dover’s President and Chief Executive Officer.
Karl Buscher, President PSG, said, “We are excited to have the opportunity to integrate Em-tec’s flow technology with our PSG pumps post-acquisition to provide smarter solutions to our customers where critical flow control is paramount.”
Terms of the transaction were not disclosed. The transaction is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, and is expected to close in the second quarter of 2020.